Alar Pharmaceuticals Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1,821	1,793	1,406	739.46	455.35	519.07
Short-Term Investments	482.9	502.9	1,025	156.53	30.87	-
Cash & Short-Term Investments	2,303	2,296	2,431	895.99	486.22	519.07
Cash Growth	-4.50%	-5.54%	171.32%	84.28%	-6.33%	-7.47%
Receivables	0.26	-	-	-	0.84	-
Prepaid Expenses	24.11	41.95	2	3.56	9.96	9.62
Other Current Assets	13.47	14.31	8.58	3.47	0.55	0.01
Total Current Assets	2,341	2,353	2,442	903.02	497.57	528.69
Property, Plant & Equipment	15.32	16.95	13.58	12.77	9.78	9.1
Long-Term Investments	69.74	69.17	21.46	-	-	-
Long-Term Deferred Tax Assets	48.18	48.2	48.27	54.97	13	-
Other Long-Term Assets	0.6	0.6	31.2	2.45	2.25	2.11
Total Assets	2,475	2,488	2,556	973.21	522.6	539.91
Accrued Expenses	-	22.28	6.69	20.48	2.02	2.17
Current Portion of Leases	2.69	3.57	0.3	1.27	1.29	0.68
Current Income Taxes Payable	46.97	46.97	45.67	49.45	-	-
Current Unearned Revenue	-	-	1.25	1.25	-	-
Other Current Liabilities	43.97	1.64	1.16	2.32	2.06	1.61
Total Current Liabilities	93.63	74.47	55.08	74.77	5.37	4.46
Long-Term Leases	-	-	0.31	0.14	1.41	0.27
Long-Term Deferred Tax Liabilities	11.65	8.12	7.39	-	0.33	-
Other Long-Term Liabilities	1.82	1.75	1.49	1.18	0.99	0.81
Total Liabilities	107.1	84.34	64.26	76.09	8.1	5.54
Common Stock	668	668	668	570	570	570
Additional Paid-In Capital	1,579	1,579	1,579	-	-	424.04
Retained Earnings	113.53	148.7	245.09	327.12	-55.5	-459.67
Comprehensive Income & Other	7.74	7.74	-	-	-	-
Shareholders' Equity	2,368	2,403	2,492	897.12	514.5	534.37
Total Liabilities & Equity	2,475	2,488	2,556	973.21	522.6	539.91
Total Debt	2.69	3.57	0.6	1.41	2.69	0.95
Net Cash (Debt)	2,301	2,293	2,430	894.58	483.53	518.12
Net Cash Growth	-4.50%	-5.66%	171.69%	85.01%	-6.68%	-7.39%
Net Cash Per Share	34.44	34.32	36.70	15.68	8.48	9.09
Filing Date Shares Outstanding	66.8	66.8	66.8	57	57	57
Total Common Shares Outstanding	66.8	66.8	66.8	57	57	57
Working Capital	2,248	2,278	2,387	828.25	492.2	524.24
Book Value Per Share	35.45	35.98	37.30	15.74	9.03	9.37
Tangible Book Value	2,368	2,403	2,492	897.12	514.5	534.37
Tangible Book Value Per Share	35.45	35.98	37.30	15.74	9.03	9.37
Machinery	-	28.8	27.15	22.99	16.65	16.42
Leasehold Improvements	-	2.2	0.98	0.98	0.98	1.05